Recro Pharma, Inc. License Agreements
8 Contracts & Agreements
- Amendment No. 3 to License and Supply Agreement, dated as of July 1, 2022 by and among Societal CDMO Gainesville LLC and Lannett Company, Inc (Filed With SEC on August 10, 2022)
- Amendment No. 2 to License and Supply Agreement, dated as of November 5, 2020 by and among Recro Gainesville LLC, Kremers Urban Pharmaceuticals, Inc. and Lannett Company, Inc (Filed With SEC on November 9, 2020)
- Amendment No. 1 to License and Supply Agreement, dated as of September 6, 2018, by and between Recro Gainesville LLC and Kremers Urban Pharmaceuticals, Inc (Filed With SEC on March 4, 2020)
- License and Supply Agreement, dated as of January 1, 2014, by and between Alkermes Pharma Ireland Limited and Kremers Urban Pharmaceuticals, Inc (Filed With SEC on March 4, 2020)
- Supplemental Agreement No. 3 to the Amended and Restated License and Supply Agreement, dated as of April 15, 2019, by and between Recro Gainesville LLC and Teva Pharmaceutical... (Filed With SEC on April 18, 2019)
- Amendment to License Agreement, dated October 31, 2018, by and between Cornell University and Recro Pharma, Inc (Filed With SEC on February 19, 2019)
- Second Amendment to Asset Transfer and License Agreement, dated December 20, 2018, by and between Recro Gainesville LLC and Alkermes Pharma Ireland Limited (Filed With SEC on December 28, 2018)
- AMENDMENT TO ASSET TRANSFER AND LICENSE AGREEMENT (Filed With SEC on December 23, 2015)
